Ronald Andrews

2021

In 2021, Ronald Andrews earned a total compensation of $2.9M as Former President and Chief Executive Officer at Oncocyte Corp, a 179% increase compared to previous year.

Compensation breakdown

Bonus$297,600
Option Awards$2,120,000
Salary$480,000
Other$24,238
Total$2,921,838

Andrews received $2.1M in option awards, accounting for 73% of the total pay in 2021.

Andrews also received $297.6K in bonus, $480K in salary and $24.2K in other compensation.

Rankings

In 2021, Ronald Andrews' compensation ranked 4,525th out of 12,412 executives tracked by ExecPay. In other words, Andrews earned more than 63.5% of executives.

ClassificationRankingPercentile
All
4,525
out of 12,412
64th
Division
Manufacturing
1,869
out of 5,498
66th
Major group
Chemicals And Allied Products
776
out of 2,374
67th
Industry group
Drugs
690
out of 2,095
67th
Industry
In Vitro and In Vivo Diagnostic Substances
14
out of 61
77th
Source: SEC filing on May 19, 2023.

Andrews' colleagues

We found one more compensation record of an executive who worked with Ronald Andrews at Oncocyte Corp in 2021.

2021

Douglas Ross

Oncocyte Corp

Chief Scientific Officer

News

In-depth

You may also like